Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GSK announces FDA approval of seasonal flu virus vaccine in US
The intramuscular vaccine is developed to prevent diseases caused by two strains each of seasonal flu virus subtypes A and type B. GSK North America vaccines clinical development
The intramuscular vaccine is developed to prevent diseases caused by two strains each of seasonal flu virus subtypes A and type B. GSK North America vaccines clinical development
The products include Chemet (succimer), Cosmegen (dactinomycin for injection), Desoxyn (methamphetamine hydrochloride), Elspar (asparaginase), Indocin (indomethacin), Mustargen (mechlorethamine HCL for injection), NeoProfen (ibuprofen lysine), Panhematin (hemin), Peganone (ethotoin)
The research deal will focus on the identification of the compounds targeting nuclear hormone receptor ROR?T and optimized for preclinical development. Advancement of the compounds resulting from the
Antares Pharma president and chief executive officer Paul Wotton said Otrexup is the first product designed for convenient subcutaneous delivery of MTX in patients with rheumatoid arthritis (RA)
Clarity 4D Monitoring software with autoscan acquisition technology, will enable physicians to monitor the motion of the prostate and surrounding tissues and organs in real-time and with sub-millimeter
The acquisition of the Seattle-based Super Supplements that operates 31 stores in Washington, Oregon and Idaho, US, is expected to expand the Vitamin Shoppe’s Pacific Northwest business. The
PMI features the MMRF’s CoMMpass study (Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile). Under the study, PCC, which includes Millennium: The Takeda Oncology
As part of the agreement, LCT will receive an upfront payment of A$3m ($3.5m) within 30 days of signing as well as further milestone payment of A$2m($2m) on
The acquisition included purchase of all the shares of the entities through which Banner conducts its operations for a purchase price of nearly $255m, subject to adjustment for
Avid Bioservices quality vice president Jeff Masten said the rollout of recent facility enhancements, as well as the plans for the next phases, requires timely, accurate and strategic